DJIA 15,303.10 8.60 0.06%
NASDAQ 3,459.14 -0.28 -0.01%
S&P 500 1,649.60 -0.91 -0.06%

Merck & Co., Inc.

NYSE: MRK

47.16 -0.17 (-0.36%)

REAL-TIME: Last trade at

company name or ticker

Recent Quotes

MRK $47.16 -0.36%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $47.05
Previous Close $47.33
Daily Range $46.60 - $47.16
52-Week Range $37.02 - $48.79
Market Cap $142.4B
P/E Ratio 24.15
Dividend (Yield) $1.72 (3.6%)
Ex-Dividend Date
Dividend Pay Date
03/13/13
04/05/13
Volume 15,795,941
Average Daily Volume 17,266,540
Current FY EPS $3.49

Sector

Healthcare

Industry

Drugs

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

News & Commentary Rss Feed

Stalled Progress in the Fight Against HIV?

Another HIV vaccine bites the dust. Has progress in the fight against HIV stalled?

Leon Cooperman's First Quarter Increases

Leon Cooperman's First Quarter Increases

Why Immunotherapy Stocks Could Be Set for a Big Move

The American Society of Clinical Oncology's annual meeting kicks off late next week, and this group of stocks looks primed to impress analysts and investors alike.

Merck Halts Parkinson's Drug Trials

The health care giant doesn’t obtain the desired results, opts to discontinue preladenant drug trials.

Merck & Co Inc Stock Buy Recommendation Reiterated (MRK)

Unclear Future for Merck's Insomnia Drug

The FDA advisory committee has discussed Suvorexant; now shareholders need to get ready for the agency's final decision this summer.

Merck Discontinues Studies on Preladenant Drug

Merck Stock Is a Good Investment (According to Merck)

Merck accelerates its buyback.

Merck halts development of experimental Parkinson's drug

See More MRK News...

MRK's Top Competitors

MRK $47.16 (-0.36%)
Current stock: MRK
JNJ $86.82 (-0.45%)
Current stock: JNJ
NVS $74.36 (0.73%)
Current stock: NVS
RHHBY $65.96 (0.61%)
Current stock: RHHBY